Inspire Investing LLC lessened its holdings in shares of Revvity, Inc. (NYSE:RVTY – Free Report) by 39.7% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,527 shares of the company’s stock after selling 1,663 shares during the period. Inspire Investing LLC’s holdings in Revvity were worth $265,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Czech National Bank raised its stake in Revvity by 0.5% during the 1st quarter. Czech National Bank now owns 21,713 shares of the company’s stock valued at $2,280,000 after acquiring an additional 99 shares in the last quarter. Garrison Asset Management LLC raised its stake in shares of Revvity by 0.5% in the 2nd quarter. Garrison Asset Management LLC now owns 21,328 shares of the company’s stock worth $2,236,000 after buying an additional 103 shares in the last quarter. TriaGen Wealth Management LLC grew its holdings in Revvity by 2.3% during the second quarter. TriaGen Wealth Management LLC now owns 4,767 shares of the company’s stock worth $500,000 after acquiring an additional 107 shares during the period. Guinness Asset Management LTD raised its position in Revvity by 3.3% in the second quarter. Guinness Asset Management LTD now owns 3,587 shares of the company’s stock worth $376,000 after acquiring an additional 116 shares in the last quarter. Finally, Tokio Marine Asset Management Co. Ltd. lifted its holdings in Revvity by 3.6% in the 1st quarter. Tokio Marine Asset Management Co. Ltd. now owns 3,899 shares of the company’s stock valued at $409,000 after acquiring an additional 135 shares during the last quarter. 86.65% of the stock is currently owned by institutional investors and hedge funds.
Insider Transactions at Revvity
In related news, insider Joel S. Goldberg sold 3,500 shares of the company’s stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $117.86, for a total value of $412,510.00. Following the completion of the sale, the insider now directly owns 33,400 shares in the company, valued at $3,936,524. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.60% of the stock is currently owned by company insiders.
Analyst Upgrades and Downgrades
Check Out Our Latest Report on RVTY
Revvity Trading Up 2.4 %
Revvity stock opened at $124.94 on Wednesday. Revvity, Inc. has a 12 month low of $79.50 and a 12 month high of $128.15. The company has a quick ratio of 1.98, a current ratio of 2.27 and a debt-to-equity ratio of 0.40. The stock has a market cap of $15.42 billion, a P/E ratio of 103.26, a P/E/G ratio of 2.87 and a beta of 1.05. The company’s fifty day simple moving average is $119.58 and its 200-day simple moving average is $110.83.
Revvity (NYSE:RVTY – Get Free Report) last issued its earnings results on Monday, July 29th. The company reported $1.22 earnings per share for the quarter, topping the consensus estimate of $1.12 by $0.10. The company had revenue of $691.70 million for the quarter, compared to analyst estimates of $690.33 million. Revvity had a return on equity of 7.34% and a net margin of 6.26%. The business’s revenue was down 2.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.21 EPS. As a group, sell-side analysts forecast that Revvity, Inc. will post 4.75 EPS for the current fiscal year.
Revvity Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, November 8th. Shareholders of record on Friday, October 18th will be given a $0.07 dividend. This represents a $0.28 annualized dividend and a yield of 0.22%. The ex-dividend date is Friday, October 18th. Revvity’s dividend payout ratio is 23.14%.
Revvity Company Profile
Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.
Featured Articles
- Five stocks we like better than Revvity
- Insider Trades May Not Tell You What You Think
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- How to invest in marijuana stocks in 7 steps
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Want to see what other hedge funds are holding RVTY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Revvity, Inc. (NYSE:RVTY – Free Report).
Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with MarketBeat.com's FREE daily email newsletter.